Old Web
English
Sign In
Acemap
>
authorDetail
>
Y. Anne Pak
Y. Anne Pak
Eli Lilly and Company
Pharmacology
Transporter
Medicine
IC50
In vivo
4
Papers
100
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate
2019
Clinical Pharmacology & Therapeutics
Jill Chappell
P. Kellie Turner
Y. Anne Pak
James A. Bacon
Alan Y. Chiang
Jane Royalty
Stephen D. Hall
Palaniappan Kulanthaivel
Joseph V. Bonventre
Show All
Source
Cite
Save
Citations (26)
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective
2018
Clinical Pharmacology & Therapeutics
J. Gerry Kenna
Kunal S. Taskar
Christina Battista
David L. Bourdet
Kim L. R. Brouwer
Kenneth R. Brouwer
David Dai
Christoph Funk
Michael J. Hafey
Yurong Lai
Jonathan Maher
Y. Anne Pak
Jenny M. Pedersen
Joseph W. Polli
A. David Rodrigues
Paul B. Watkins
Kyunghee Yang
Robert Yucha
Show All
Source
Cite
Save
Citations (37)
Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib
2017
Clinical and Translational Science
Maria Posada
Ellen A. Cannady
Christopher D. Payne
Xin Zhang
James A. Bacon
Y. Anne Pak
J. William Higgins
Nazila Shahri
Stephen D. Hall
Kathleen M. Hillgren
Show All
Source
Cite
Save
Citations (30)
In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
2017
Drug Metabolism and Disposition
Y. Anne Pak
Amanda J. Long
William F. Annes
Jennifer Witcher
Mary Pat Knadler
Mosun Ayan-Oshodi
Malcolm I. Mitchell
Phillip Leese
Kathleen M. Hillgren
Show All
Source
Cite
Save
Citations (7)
1